Posted by admin on Aug 16th, 2022

StockNews.com cut shares of DENTSPLY SIRONA (NASDAQ:XRAY – Get Rating) from a buy rating to a hold rating in a research report report published on Monday morning.

XRAY has been the subject of several other research reports. Robert W. Baird downgraded shares of DENTSPLY SIRONA from an outperform rating to a neutral rating and lowered their target price for the company from $67.00 to $48.00 in a research note on Tuesday, April 19th. William Blair cut shares of DENTSPLY SIRONA from a market perform rating to an underperform rating in a report on Friday, August 5th. HC Wainwright reduced their price target on shares of DENTSPLY SIRONA from $58.00 to $48.00 and set a hold rating for the company in a report on Friday, April 22nd. Bank of America cut shares of DENTSPLY SIRONA from a buy rating to a neutral rating and reduced their price target for the company from $66.00 to $49.00 in a report on Tuesday, April 19th. Finally, UBS Group upgraded shares of DENTSPLY SIRONA from a neutral rating to a buy rating and reduced their price target for the company from $58.00 to $47.00 in a report on Wednesday, June 1st. One analyst has rated the stock with a sell rating, six have given a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, DENTSPLY SIRONA currently has a consensus rating of Hold and a consensus target price of $48.11.

Shares of NASDAQ:XRAY opened at $37.60 on Monday. DENTSPLY SIRONA has a 52 week low of $33.78 and a 52 week high of $63.10. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.03 and a current ratio of 1.45. The company has a market capitalization of $8.10 billion, a PE ratio of 22.25, a PEG ratio of 3.05 and a beta of 0.91. The company has a 50 day moving average price of $36.20 and a two-hundred day moving average price of $43.16.

The company also recently declared a quarterly dividend, which will be paid on Friday, October 14th. Shareholders of record on Friday, September 30th will be paid a $0.125 dividend. This represents a $0.50 dividend on an annualized basis and a yield of 1.33%. The ex-dividend date of this dividend is Thursday, September 29th. DENTSPLY SIRONA’s dividend payout ratio is currently 29.59%.

Large investors have recently added to or reduced their stakes in the company. SOA Wealth Advisors LLC. lifted its stake in DENTSPLY SIRONA by 26,666.7% in the first quarter. SOA Wealth Advisors LLC. now owns 803 shares of the medical instruments supplier’s stock valued at $39,000 after acquiring an additional 800 shares during the last quarter. Van ECK Associates Corp acquired a new stake in DENTSPLY SIRONA in the second quarter valued at $41,000. Parkside Financial Bank & Trust lifted its stake in DENTSPLY SIRONA by 33.8% in the second quarter. Parkside Financial Bank & Trust now owns 1,224 shares of the medical instruments supplier’s stock valued at $43,000 after acquiring an additional 309 shares during the last quarter. Dixon Hughes Goodman Wealth Advisors LLC acquired a new stake in DENTSPLY SIRONA in the first quarter valued at $79,000. Finally, Covestor Ltd acquired a new stake in DENTSPLY SIRONA in the fourth quarter valued at $90,000. Institutional investors and hedge funds own 94.79% of the company’s stock.

DENTSPLY SIRONA Inc designs, develops, manufactures, distributes, and sells various dental products and technologies for professional dental market worldwide. It offers dental equipment, including treatment centers, imaging equipment, motorized dental handpieces, and other instruments; imaging equipment; treatment centers comprising basic dentist chairs, sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, and specialist centers; and lab equipment, such as amalgamators, mixing machines, and porcelain furnaces.

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.

Leafly (NASDAQ:LFLY) Price Target Lowered to $4.00 at Cowen

2seventy bio (NASDAQ:TSVT) Price Target Lowered to $27.00 at Morgan Stanley